Showing results (191-200 of 227) with videos related to
Sort By:
Pageof 23
Journal of the Peripheral Nervous System : JPNS|January 24, 2019
Restabilization treatment after intravenous immunoglobulin withdrawal in chronic inflammatory demyelinating polyneuropathy: Results from the pre-randomization phase of the Polyneuropathy And Treatment with Hizentra studyOrell Mielke, Vera Bril, David R Cornblath, et al.The Lancet. Neurology|November 11, 2017
Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trialIvo N van Schaik, Vera Bril, Nan van Geloven, et al.Nature|September 16, 2021
UTX condensation underlies its tumour-suppressive activityBi Shi, Wei Li, Yansu Song, et al.Neurology(R) Neuroimmunology & Neuroinflammation|July 30, 2019
Long-term safety and efficacy of subcutaneous immunoglobulin IgPro20 in CIDP: PATH extension studyIvo N van Schaik, Orell Mielke, Vera Bril, et al.Allergy|October 7, 2024
Long-term safety and efficacy of garadacimab for preventing hereditary angioedema attacks: Phase 3 open-label extension studyAvner Reshef, Connie Hsu, Constance H Katelaris, et al.Molecular & Cellular Proteomics : MCP|July 25, 2014
Inhibition of circulating dipeptidyl peptidase 4 activity in patients with metastatic prostate cancerArpi Nazarian, Kevin Lawlor, San San Yi, et al.The Lancet Regional Health. Europe|September 15, 2025
Adolescent mental health before, during, and after the COVID-19 pandemic in Iceland: a repeated, cross-sectional, population-based studyErin Haskell, Berglind Sigmarsdottir, Ingibjorg Eva Thorisdottir, et al.Journal of Pathology Informatics|October 9, 2023
Digital pathology operations at a tertiary cancer center: Infrastructure requirements and operational costOrly Ardon, Eric Klein, Allyne Manzo, et al.Cell Reports|August 23, 2018
BET Inhibition-Induced GSK3β Feedback Enhances Lymphoma Vulnerability to PI3K InhibitorsEnrico Derenzini, Patrizia Mondello, Tatiana Erazo, et al.The Journal of Clinical Investigation|January 6, 2006
Differential exoprotease activities confer tumor-specific serum peptidome patternsJosep Villanueva, David R Shaffer, John Philip, et al.Pageof 23